Zymeworks logo

Zymeworks Share Price (NYSE: ZYME)

$14.35

0.03

(0.21%)

Live

Last updated on

Check the interactive Zymeworks Stock chart to analyse performance

Zymeworks stock performance

as on August 21, 2025 at 11:47 PM IST

  • Today's Low:$14.21
    Today's High:$14.35

    Day's Volatility :1.01%

  • 52 Weeks Low:$9.03
    52 Weeks High:$17.70

    52 Weeks Volatility :48.98%

Zymeworks Stock Returns

PeriodZymeworks IncRussel 2000Index (Russel 2000)
3 Months
23.87%
0.0%
0.0%
6 Months
1.43%
0.0%
0.0%
1 Year
28.11%
0.0%
0.0%
3 Years
122.19%
-9.6%
-9.6%

Zymeworks Inc Key Stats

Check Zymeworks key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$14.32
Open
$14.24
Today's High
$14.52
Today's Low
$14.205
Market Capitalization
$1.1B
Today's Volume
$247.3K
52 Week High
$17.7
52 Week Low
$9.03
Revenue TTM
$122.9M
EBITDA
$-72.6M
Earnings Per Share (EPS)
$-0.98
Profit Margin
-59.96%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.89%

Stock Returns calculator for Zymeworks Stock including INR - Dollar returns

The Zymeworks stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Zymeworks investment value today

Current value as on today

₹1,33,206

Returns

₹33,206

(+33.21%)

Returns from Zymeworks Stock

₹29,279 (+29.28%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Zymeworks Stock

78%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Zymeworks Stock from India on INDmoney has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Zymeworks Inc

  • Name

    Holdings %

  • EcoR1 Capital, LLC

    30.46%

  • Rubric Capital Management LP

    5.75%

  • Bvf Inc

    5.71%

  • Redmile Group, LLC

    5.50%

  • BlackRock Inc

    5.42%

  • Morgan Stanley - Brokerage Accounts

    5.40%

Analyst Recommendation on Zymeworks Stock

Rating
Trend

Buy

    71%Buy

    28%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Zymeworks(by analysts ranked 0 to 5 stars)

Zymeworks Share Price Target

What analysts predicted

Upside of 52.54%

Target:

$21.89

Current:

$14.35

Zymeworks share price target is $21.89, a slight Upside of 52.54% compared to current price of $14.35 as per analysts' prediction.

Zymeworks Stock Insights

  • Price Movement

    In the last 3 years, ZYME stock has moved up by 124.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 27.11M → 48.72M (in $), with an average increase of 44.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -37.68M → 2.31M (in $), with an average increase of 283.5% per quarter
  • ZYME vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 36.0%
  • Price to Sales

    ForZYME every $1 of sales, investors are willing to pay $8.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Zymeworks Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$76.3M
↑ 0.38%
Net Income
$-122.7M
↑ 3.39%
Net Profit Margin
-160.8%
↓ 4.67%

Zymeworks Technicals Summary

Sell

Neutral

Buy

Zymeworks is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Zymeworks Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Zymeworks Inc logo
-0.7%
1.43%
28.11%
122.19%
-55.62%
Regeneron Pharmaceuticals, Inc. logo
5.39%
-15.07%
-50.13%
-3.42%
-0.61%
Beone Medicines Ltd logo
4.61%
26.63%
56.19%
78.75%
30.26%
Vertex Pharmaceuticals Incorporated logo
-16.11%
-17.89%
-18.87%
34.22%
47.47%
Alnylam Pharmaceuticals, Inc. logo
40.82%
82.49%
64.08%
110.21%
247.67%

About Zymeworks Inc

Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies that enable the selective modulation of recruited cytotoxic immune cells for various therapeutic applications; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead product candidate consists of zanidatamab, a novel bispecific antibody that targets human epidermal growth factor receptor 2 HER2 that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. In addition, the company develops a pipeline of preclinical product candidates. It has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.
Organization
Zymeworks
Employees
273
CEO
Mr. Kenneth H. Galbraith C.A.
Industry
Health Technology

Key Management of Zymeworks Inc

NameTitle
Mr. Kenneth H. Galbraith C.A.
Chairman of the Board, CEO & President
Dr. Paul A. Moore Ph.D.
Chief Scientific Officer
Mr. Mark Hollywood
Executive VP and Head of Technical & Manufacturing Operations
Ms. Shrinal Inamdar
Director of Investor Relations
Mr. Daniel Dex J.D., Ph.D.
Senior VP, Corporate Secretary & General Counsel
Diana Papove
Senior Manager of Corporate Communications
Dr. Lindsey Foulkes B.Sc., Ph.D.
Vice President of Corporate Development
Ms. Laura O'Connor
Vice President of Human Resources & DEI
Dr. Jeffrey Smith M.D.
Executive VP & Chief Medical Officer
Mr. John Fann Ph.D.
Senior Vice President of Process Sciences

Important FAQs about investing in ZYME Stock from India :

What is Zymeworks share price today?

Zymeworks share price today is $14.35 as on . Zymeworks share today touched a day high of $14.35 and a low of $14.21.

What is the 52 week high and 52 week low for Zymeworks share?

Zymeworks share touched a 52 week high of $17.70 and a 52 week low of $9.03. Zymeworks stock price today i.e. is trending at $14.35, lower by 18.93% versus the 52 week high.

How to invest in Zymeworks Stock (ZYME) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zymeworks on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zymeworks Shares that will get you 0.1045 shares as per Zymeworks share price of $14.35 per share as on August 21, 2025 at 11:47 PM IST.

What is the minimum amount required to buy Zymeworks Stock (ZYME) from India?

Indian investors can start investing in Zymeworks (ZYME) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Zymeworks stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Zymeworks share’s latest price of $14.35 as on August 21, 2025 at 11:47 PM IST, you will get 0.6969 shares of Zymeworks. Learn more about fractional shares .

What are the returns that Zymeworks has given to Indian investors in the last 5 years?

Zymeworks stock has given -55.62% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?